Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» High Plavix doses overcome genetic barrier-study
High Plavix doses overcome genetic barrier-study
High Plavix doses overcome genetic barrier-study
Submitted by
admin
on November 16, 2011 - 9:46am
Source:
Reuters
News Tags:
Plavix
bloodthinners
Sanofi
Bristol-Myers Squibb
Headline:
High Plavix doses overcome genetic barrier-study
Do Not Allow Advertisers to Use My Personal information